BOULDER, Colo.–(BUSINESS WIRE)– #AI–1 in 8 US adults are reported to use GLP-1 medications, but the majority of people who primarily take them for weight loss stop using them within one year of starting [1,2]. A recent meta-analysis by the University of Oxford estimated that any benefits on body weight and other metabolic health markers, such as HbA1c, are lost in the majority of people who stop GLP-1 medications, and that weight regain post-GLP-1 is faster than after non-drug weight management pr
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
